Document:

Exhibit
10.4

 

Melt
Pharmaceuticals, Inc.

Non-Employee
Director

Deferred Issuance Restricted Stock Unit Grant Notice

(2018
Equity Incentive Plan)

 

Melt
Pharmaceuticals, Inc. (the “Company”), pursuant to its 2018 Equity Incentive Plan (the “Plan”),
hereby awards to Participant a Restricted Stock Unit Award for the number of Restricted Stock Units (“Units”)
set forth below (the “Award”). The Award is subject to all of the terms and conditions as set forth herein
and in the Plan and the Deferred Issuance Restricted Stock Unit Award Agreement, both of which are attached hereto and incorporated herein
in their entirety. Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan or the Deferred Issuance
Restricted Stock Unit Award Agreement. In the event of any conflict between the terms in this Grant Notice or the Deferred Issuance Restricted
Stock Unit Award Agreement and the Plan, the terms of the Plan will control.

 

	Participant:	 	 	 
	Date
    of Grant:	 	 	 
	Vesting
    Commencement Date:	 	 	 
	Number
    of Units Subject to Award:	 	 	 

 

	Vesting
    Schedule: 	 	[●]
	 	 	 
	Deferred
    Issuance Schedule: 	 	One
    share of Common Stock will be issued for each Unit which vests at the time set forth in Section 6 of the Award Agreement.

 

Additional
Terms/Acknowledgements: Participant acknowledges receipt of, and understands and agrees to, this Deferred Issuance Restricted Stock
Unit Grant Notice, the Deferred Issuance Restricted Stock Unit Award Agreement and the Plan. Participant further acknowledges that as
of the Date of Grant, this Deferred Issuance Restricted Stock Unit Grant Notice, the Deferred Issuance Restricted Stock Unit Award Agreement,
and the Plan set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior oral
and written agreements, promises and/or representations on that subject with the if applicable, of (i) the written service agreement,
offer letter or other written agreement entered into between the Company and Participant specifying the terms that govern this Award,
and (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by applicable law.

 

By
accepting this Award Participant acknowledges having received and read this Deferred Issuance Restricted Stock Unit Grant Notice, the
Deferred Issuance Restricted Stock Unit Award Agreement and the Plan and agrees to all of the terms and conditions set forth in these
documents. Participant consents to receive Plan documents by electronic delivery and to participate in the Plan through an on-line or
electronic system established and maintained by the Company or another third party designated by the Company.

 

	Melt
    Pharmaceuticals, Inc.	 	Participant: 
	 	 	 
	 	 	 
	[Name]	                       	 	[Name]	                       
	[Title]	 	 	 	 
	 	 	 	 	 
	Date:	 	 	Date:	 

 

	Attachments:	 	Deferred Issuance Restricted Stock Unit Award Agreement

                                                                                2018 Equity Incentive Plan

 

    	 

    	 

    

 

Attachment
I

 

Melt
Pharmaceuticals, Inc.

Non-Employee
Director

Deferred
Issuance Restricted Stock Unit Award Agreement

(2018
Equity Incentive Plan)

 

Pursuant
to the Deferred Issuance Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Deferred Issuance
Restricted Stock Unit Award Agreement (the “Agreement”) and in consideration of your services, Melt Pharmaceuticals,
Inc. (the “Company”) has awarded you a Deferred Issuance Restricted Stock Unit Award (the “Award”)
under its 2018 Equity Incentive Plan (the “Plan”). The Award is granted to you effective as of the Date of
Grant set forth in the Grant Notice for this Award. Certain capitalized terms used in this Agreement have the meanings set forth in Section
7 below. Capitalized terms not explicitly defined in this Agreement will have the same meanings given to them in the Plan. In the event
of any conflict between the terms in this Agreement and the Plan, the terms of the Plan will control. The details of the Award, in addition
to those set forth in the Grant Notice and the Plan, are as follows.

 

1.
Grant of the Award. The Award represents the right to be issued on a future date the
number of shares of the Company’s Common Stock equal to the number of Units subject to the Award as indicated in the Grant Notice
upon the satisfaction of the terms set forth in this Agreement. Except as otherwise provided herein, you will not be required to make
any payment to the Company with respect to your receipt of the Award, the vesting of the Units or the delivery of the Common Stock in
settlement of the vesting of the Units subject to the Award.

 

2.
Vesting. Subject to the limitations contained herein, the Award will vest, if at all,
in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous
Service. Upon such termination of your Continuous Service, the Units subject to the Award that were not vested on the date of such termination
will be forfeited at no cost to the Company and you will have no further right, title or interest in or to such Units or any shares of
Common Stock in settlement of such Units.

 

3.
Number of Shares.

 

(a)
The number of Units subject to the Award may be adjusted from time to time for Capitalization Adjustments, as provided in the Plan.

 

(b)
Any shares, cash or other property that becomes subject to the Award pursuant to this Section 3, if any, will be subject, in a manner
determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable
to the other shares that may be issued in settlement of the Award.

 

(c)
Notwithstanding the provisions of this Section 3, no fractional Units or rights for fractional shares of Common Stock will be created
pursuant to this Section 3. The Board will, in its discretion, determine an equivalent benefit for any fractional Units or rights to
fractional shares that might be created by the adjustments referred to in this Section 3.

 

4.
Securities Law and Other Compliance. You may not be issued any shares under the Award
unless either (a) the shares are registered under the Securities Act; or (b) the Company has determined that such issuance would be exempt
from the registration requirements of the Securities Act. The Award also must comply with other applicable laws and regulations governing
the Award, and you will not receive such shares if the Company determines that such receipt would not be in material compliance with
such laws and regulations.

 

    	1.

    	 

    

 

5.
Transfer Restrictions.

 

(a)
General. Prior to the time that shares of Common Stock have been delivered to you, you may not transfer, pledge, sell or otherwise
dispose of this Award or the shares issuable in respect of the Award, except as expressly provided in this Section 5. For example, you
may not use shares that may be issued in respect of the Award as security for a loan. The restrictions on transfer set forth herein will
lapse upon delivery to you of shares in respect of the vested portion of the Award.

 

(b)
Death. The Award is transferable by will and by the laws of descent and distribution. In addition, upon receiving written permission
from the Board or its duly authorized designee, you may, by delivering written notice to the Company, in a form provided by or otherwise
satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who,
in the event of your death, will thereafter be entitled to receive any distribution of Common Stock or other consideration to which you
were entitled at the time of your death pursuant to this Agreement. In the absence of such a designation, your executor or administrator
of your estate will be entitled to receive, on behalf of your estate, such Common Stock or other consideration.

 

(c)
Certain Trusts. Upon receiving written permission from the Board or its duly authorized designee, you may transfer the Award to a
trust if you are considered to be the sole beneficial owner (determined under Section 671 of the Code and applicable state law) while
the Award is held in the trust, provided that you and the trustee enter into transfer and other agreements required by the Company.

 

(d)
Domestic Relations Orders. Upon receiving written permission from the Board or its duly authorized designee, and provided that you
and the designated transferee enter into transfer and other agreements required by the Company, you may transfer the Award or your right
to receive the distribution of Common Stock or other consideration thereunder, pursuant to a domestic relations order that contains the
information required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any division of this
Award with the Company prior to finalizing the domestic relations order to help ensure the required information is contained within the
domestic relations order.

 

6.
Deferred Dates of Issuance. 

 

(a)
Subject to the provisions of Sections 6(b) below, if the Units vest, the Company shall deliver to you shares of Common Stock in settlement
of any previously vested Units subject to the Award immediately upon the earliest of the following dates that occurs:

 

(i)
the thirtieth (30th) day following your death;

 

(ii)
the thirtieth (30th) day following your Section 409A Disability;

 

(iii)
the date of a Section 409A Change of Control; or

 

(iv)
the thirtieth (30th) day following your Separation from Service; provided, however, if as of the date of your Separation
from Service you are a “specified employee” (as defined under Treasury Regulations Section 1.409A-1(i)) to the extent necessary
to avoid adverse tax consequences to you under Section 409A of the Code, the issuance of the shares will instead occur on the earlier
of: (i) the date that is the thirtieth (30th) day following your death and (ii) date that is six (6) months and one (1) day
after your Separation from Service.

 

    	2.

    	 

    

 

(b)
Notwithstanding the foregoing provisions of this Section 6, in the event that (i) you are subject to the Company’s policy permitting
certain individuals to sell shares only during certain “window” periods, in effect from time to time or you are otherwise
prohibited from selling shares of the Company’s Common Stock in the public market and any shares in settlement of the Award are
scheduled to be delivered on a day (the “Original Distribution Date”) that does not occur during an open “window
period” applicable to you, as determined by the Company in accordance with such policy, or does not occur on a date when you are
otherwise permitted to sell shares of the Company’s Common Stock on the open market, (ii) you are subject to withholding for Tax-Related
Items, and (iii) the Company elects not to satisfy its obligations for Tax-Related Items (as defined in Section 11) by withholding shares
from your distribution, then such shares will not be delivered on such Original Distribution Date and will instead be delivered on the
first business day of the next occurring open “window period” applicable to you pursuant to such policy (regardless of whether
you are still providing Continuous Service at such time) or the next business day when you are not prohibited from selling shares of
the Company’s Common Stock in the open market, but in no event later than the last day of the calendar year in which the Original
Distribution Date occurs. The form of such delivery (e.g., a stock certificate or electronic entry evidencing such shares) will
be determined by the Company.

 

(c)
In all cases, the delivery of shares in settlement of this Award is intended to comply with the requirements of Section 409A of the
Code and will be construed and administered in such a manner. The Company explicitly reserves the right to provide for earlier issuance
of the shares in settlement of the Award to the extent permitted by Section 409A of the Code.

 

7.
Definitions. As used in this Agreement, the following terms have the following meanings:

 

(a)
“Section 409A Change of Control” shall mean the Company consummates a transaction or series of transactions
constituting a Change in Control and which also results in a “change in ownership or effective control of” the Company or
a change “in the ownership of a substantial portion of the assets of” the Company (as defined in Treasury Regulation Sections
1.409A-3(i)(5)(v), (vi) and (vii), without regard to any alternative definitions therein).

 

(b)
“Section 409A Disability” means your inability to engage in any substantial gainful activity by reason
of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a
continuous period of not less than 12 months, within the meaning of Section 409A(a)(2)(c)(i) of the Internal Revenue Code.

 

(c)
“Separation from Service” means your “separation from service” from the Company as defined
under Treasury Regulations Section 1.409A-1(h), without regard to any alternative definitions therein.

 

8.
Dividends. You shall receive no benefit or adjustment to your Award with respect to
any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment.

 

9.
Restrictive Legends. The shares issued under the Award will be endorsed with appropriate
legends as determined by the Company.

 

    	3.

    	 

    

 

10.
Award not a Service Contract.

 

(a)
Your Continuous Service with the Company or an Affiliate is not for any specified term and may be terminated by you or by the Company
or an Affiliate at any time, for any reason, with or without cause and with or without notice. Nothing in this Agreement (including,
but not limited to, the vesting of the Award pursuant to Section 2 or the issuance of the shares subject to the Award), the Plan or any
covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan will: (i) confer upon you any right
to continue in the service of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company
or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition
of service or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically
accrued under the terms of this Agreement or Plan; or (iv) deprive the Company or an Affiliate of the right to terminate you at will
and without regard to any future vesting opportunity that you may have.

 

(b)
By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to Section 2 and the
schedule set forth in the Grant Notice is earned only by continuing as an director, employee or consultant at the will of the Company
or an Affiliate (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has
the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time
to time, as it deems appropriate (a “reorganization”). You further acknowledge and agree that such a reorganization
could result in the termination of your Continuous Service and the loss of benefits available to you under this Agreement, including
but not limited to, the termination of the right to continue vesting in the Award. You further acknowledge and agree that this Agreement,
the Plan, the transactions contemplated hereunder and the vesting schedule set forth in the Grant Notice or any covenant of good faith
and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement as
a director, employee or consultant with the Company or an Affiliate for the term of this Agreement, for any period, or at all, and will
not interfere in any way with your right or the right of the Company or an Affiliate to terminate your Continuous Service at any time,
with or without cause and with or without notice.

 

11.
Responsibility for Taxes.

 

(a)
You acknowledge that, regardless of any action taken by the Company, the ultimate liability for all income tax, social insurance,
payroll tax, fringe benefits tax, payment on account or other tax-related items related to your participation in the Plan and legally
applicable to you or deemed by the Company in its discretion to be an appropriate charge to you even if legally applicable to the Company
(“Tax-Related Items”) is and remains your responsibility and may exceed the amount actually withheld by the
Company.

 

(b)
Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the
Company to satisfy all Tax-Related Items. In this regard, you authorize the Company or its agent to satisfy their withholding obligations
with regard to all Tax-Related Items, if any, by any of the following means or by a combination of such means: (i) withholding from any
compensation otherwise payable to you by the Company; (ii) causing you to tender a cash payment; (iii) entering on your behalf (pursuant
to this authorization without further consent) into a “same day sale” commitment with a broker dealer that is a member of
the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby you irrevocably elect to sell a portion
of the shares to be delivered under the Award to satisfy the Tax-Related Items and whereby the FINRA Dealer irrevocably commits to forward
the proceeds necessary to satisfy the Tax-Related Items directly to the Company and/or its Affiliates; or (iv) withholding shares of
Common Stock from the shares of Common Stock issued or otherwise issuable to you in connection with the Award with a Fair Market Value
(measured as of the date shares of Common Stock are issued pursuant to Section 6) equal to the amount of such Tax-Related Items. Depending
on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding
rates or other applicable withholding rates, including maximum applicable rates, in which case you will receive a refund of any over-withheld
amount in cash and will have no entitlement to the Common Stock equivalent. If the obligation for Tax-Related Items is satisfied by withholding
in shares of Common Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common Stock subject to
the vested portion of the Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of
paying the Tax-Related Items.

 

    	4.

    	 

    

 

(c)
Finally, you agree to pay to the Company any amount of Tax-Related Items that the Company may be required to withhold or account
for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse
to issue or deliver the shares or the proceeds of the sale of shares of Common Stock if you fail to comply with your obligations, if
any, in connection with the Tax-Related Items.

 

12.
No Obligation to Minimize Taxes. You acknowledge that the Company is not making representations
or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited
to, the grant, vesting or settlement of the Award, the subsequent sale of shares of Common Stock acquired pursuant to such settlement
and the receipt of any dividends and/or any dividend equivalent payments. Further, you acknowledge that the Company does not have any
duty or obligation to minimize your liability for Tax-Related Items arising from the Award and will not be liable to you for any Tax-Related
Items arising in connection with the Award. Although the Award is intended to comply with the requirements of Section 409A of the Code,
the Company makes no representations to you in that regard.

 

13.
No Advice Regarding Grant. The Company is not providing any tax, legal or financial
advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying
shares of Common Stock. You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the Tax-Related
Items arising in connection with the Award and by accepting the Award, you have agreed that you have done so or knowingly and voluntarily
declined to do so.

 

14.
Unsecured Obligation. The Award is unfunded, and as a holder of a vested Award, you
will be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares pursuant
to this Agreement. You will not have voting or any other rights as a stockholder of the Company with respect to the shares to be issued
pursuant to this Agreement until such shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will
obtain full voting and other rights as a stockholder of the Company. Nothing contained in this Agreement, and no action taken pursuant
to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company
or any other person.

 

15.
Notices. Any notices provided for in the Grant Notice, this Agreement or the Plan will
be given in writing and will be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five
(5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.
Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the
Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent
to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic
system established and maintained by the Company or another third party designated by the Company.

 

    	5.

    	 

    

 

16.
Miscellaneous.

 

(a)
The rights and obligations of the Company under the Award will be transferable to any one or more persons or entities, and all covenants
and agreements hereunder will inure to the benefit of, and be enforceable by, the Company’s successors and assigns. Your rights
and obligations under the Award may only be assigned with the prior written consent of the Company.

 

(b)
You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company
to carry out the purposes or intent of the Award.

 

(c)
You acknowledge and agree that you have reviewed the documents provided to you in relation to the Award in their entirety, have had
an opportunity to obtain the advice of counsel prior to executing and accepting the Award, and fully understand all provisions of such
documents.

 

(d)
This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies
or national securities exchanges as may be required.

 

(e)
All obligations of the Company under the Plan and this Agreement will be binding on any successor to the Company, whether the existence
of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of
the business and/or assets of the Company.

 

17.
Governing Plan Document. The Award is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of the Award, and is further subject to all interpretations, amendments, rules and regulations
which may from time to time be promulgated and adopted pursuant to the Plan. Except as expressly provided herein, in the event of any
conflict between the provisions of the Award and those of the Plan, the provisions of the Plan will control.

 

18.
Severability. If all or any part of this Agreement or the Plan is declared by any court
or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement
or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful
or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the
fullest extent possible while remaining lawful and valid.

 

19.
Effect on Other Benefit Plans. The value of the Award subject to this Agreement will
not be included as compensation, earnings, salaries, or other similar terms used when calculating benefits under any benefit plan sponsored
by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend,
modify, or terminate any of the Company’s or any Affiliate’s benefit plans.

 

20.
Amendment. This Agreement may not be modified, amended or terminated except by an instrument
in writing, signed by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be
amended solely by the Board by a writing which specifically states that it is amending this Agreement, so long as a copy of such amendment
is delivered to you, and provided that, except as otherwise expressly provided in the Plan, no such amendment adversely affecting your
rights hereunder may be made without your written consent. Without limiting the foregoing, the Board reserves the right to change, by
written notice to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the
grant as a result of any change in applicable laws or regulations or any future law, regulation, ruling, or judicial decision, provided
that any such change will be applicable only to rights relating to that portion of the Award which is then subject to restrictions as
provided herein.

 

    	6.

     

    

 

 Attachment
II 

 2018
Equity Incentive PlanExhibit
10.5

 

Melt
Pharmaceuticals, Inc.

Non-Employee
Director and Officer

Restricted
Stock Unit Grant Notice

(2018
Equity Incentive Plan)

 

Melt
Pharmaceuticals, Inc. (the “Company”), pursuant to its 2018 Equity Incentive Plan (the “Plan”),
hereby awards to Participant a Restricted Stock Unit Award for the number of Restricted Stock Units (“Units”)
set forth below (the “Award”). The Award is subject to all of the terms and conditions as set forth herein
and in the Plan and the Restricted Stock Unit Award Agreement, both of which are attached hereto and incorporated herein in their entirety.
Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan or the Restricted Stock Unit Award Agreement.
In the event of any conflict between the terms in this Grant Notice or the Restricted Stock Unit Award Agreement and the Plan, the terms
of the Plan will control.

 

	Participant:
    	____________________________	 
	Date
    of Grant: 	____________________________	 
	Vesting
    Commencement Date: 	____________________________	 
	Number
    of Units Subject to Award: 	____________________________	 

 

Vesting
Schedule:

 

Additional
Terms/Acknowledgements: Participant acknowledges receipt of, and understands and agrees to, this Restricted Stock Unit Grant Notice,
the Restricted Stock Unit Award Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this Restricted
Stock Unit Grant Notice, the Restricted Stock Unit Award Agreement, and the Plan set forth the entire understanding between Participant
and the Company regarding this Award and supersede all prior oral and written agreements, promises and/or representations on that subject
with the if applicable, of (i) the written service agreement, offer letter or other written agreement entered into between the Company
and Participant specifying the terms that govern this Award, and (ii) any compensation recovery policy that is adopted by the Company
or is otherwise required by applicable law.

 

By
accepting this Award Participant acknowledges having received and read this Restricted Stock Unit Grant Notice, the Restricted Stock
Unit Award Agreement and the Plan and agrees to all of the terms and conditions set forth in these documents. Participant consents to
receive Plan documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and
maintained by the Company or another third party designated by the Company.

 

	Melt
                                            Pharmaceuticals, Inc.

	 	Participant:

	 	 	 
	 	 	 	 
	Name:
    	                          	 	Name:
    	              
	Title:
    	 	 	 	 
	Date:		 	Date:	

 

	Attachments:	Restricted
  Stock Unit Award Agreement
		2018
  Equity Incentive Plan

 

    	 

    	 

    

 

Attachment
I

 

Melt
Pharmaceuticals, Inc.

Non-Employee
Director and Officer

Restricted
Stock Unit Award Agreement

(2018
Equity Incentive Plan)

 

Pursuant
to the Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Restricted Stock Unit Award Agreement
(the “Agreement”) and in consideration of your services, Melt Pharmaceuticals, Inc. (the “Company”)
has awarded you a Restricted Stock Unit Award (the “Award”) under its 2018 Equity Incentive Plan (the “Plan”).
The Award is granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award. Capitalized terms not explicitly
defined in this Agreement will have the same meanings given to them in the Plan. In the event of any conflict between the terms in this
Agreement and the Plan, the terms of the Plan will control. The details of the Award, in addition to those set forth in the Grant Notice
and the Plan, are as follows.

 

1.
Grant of the Award. The Award represents the right to be issued on a future date the
number of shares of the Company’s Common Stock equal to the number of Units subject to the Award as indicated in the Grant Notice
upon the satisfaction of the terms set forth in this Agreement. Except as otherwise provided herein, you will not be required to make
any payment to the Company with respect to your receipt of the Award, the vesting of the Units or the delivery of the Common Stock in
settlement of the vesting of the Units subject to the Award.

 

2.
Vesting. Subject to the limitations contained herein, the Award will vest, if at all,
in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous
Service. Upon such termination of your Continuous Service, the Units subject to the Award that were not vested on the date of such termination
will be forfeited at no cost to the Company and you will have no further right, title or interest in or to such Units or any shares of
Common Stock in settlement of such Units.

 

3.
Number of Shares.

 

(a)
The number of Units subject to the Award may be adjusted from time to time for Capitalization Adjustments, as provided in the Plan.

 

(b)
Any shares, cash or other property that becomes subject to the Award pursuant to this Section 3, if any, will be subject, in a manner
determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable
to the other shares that may be issued in settlement of the Award.

 

(c)
Notwithstanding the provisions of this Section 3, no fractional Units or rights for fractional shares of Common Stock will be created
pursuant to this Section 3. The Board will, in its discretion, determine an equivalent benefit for any fractional Units or rights to
fractional shares that might be created by the adjustments referred to in this Section 3.

 

4.
Securities Law and Other Compliance. You may not be issued any shares under the Award
unless either (a) the shares are registered under the Securities Act; or (b) the Company has determined that such issuance would be exempt
from the registration requirements of the Securities Act. The Award also must comply with other applicable laws and regulations governing
the Award, and you will not receive such shares if the Company determines that such receipt would not be in material compliance with
such laws and regulations.

 

    	1

     

    

 

5.
Transfer Restrictions.

 

(a)
General. Prior to the time that shares of Common Stock have been delivered to you, you may not transfer, pledge, sell or otherwise
dispose of this Award or the shares issuable in respect of the Award, except as expressly provided in this Section 5. For example, you
may not use shares that may be issued in respect of the Award as security for a loan. The restrictions on transfer set forth herein will
lapse upon delivery to you of shares in respect of the vested portion of the Award.

 

(b)
Death. The Award is transferable by will and by the laws of descent and distribution. In addition, upon receiving written permission
from the Board or its duly authorized designee, you may, by delivering written notice to the Company, in a form provided by or otherwise
satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who,
in the event of your death, will thereafter be entitled to receive any distribution of Common Stock or other consideration to which you
were entitled at the time of your death pursuant to this Agreement. In the absence of such a designation, your executor or administrator
of your estate will be entitled to receive, on behalf of your estate, such Common Stock or other consideration.

 

(c)
Certain Trusts. Upon receiving written permission from the Board or its duly authorized designee, you may transfer the Award to a
trust if you are considered to be the sole beneficial owner (determined under Section 671 of the Code and applicable state law) while
the Award is held in the trust, provided that you and the trustee enter into transfer and other agreements required by the Company.

 

(d)
Domestic Relations Orders. Upon receiving written permission from the Board or its duly authorized designee, and provided that you
and the designated transferee enter into transfer and other agreements required by the Company, you may transfer the Award or your right
to receive the distribution of Common Stock or other consideration thereunder, pursuant to a domestic relations order that contains the
information required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any division of this
Award with the Company prior to finalizing the domestic relations order to help ensure the required information is contained within the
domestic relations order.

 

6.
Settlement. Unless the Board, in its sole discretion, provides you with an election
form pursuant to which you may elect otherwise, you will be entitled to settlement of the Common Stock subject to this Award, or the
applicable portion thereof, at the time that the Units subject to this Award, or applicable portion thereof, vests in accordance with
Section 2. Such settlement shall be made as promptly as reasonably practicable thereafter (but in no event after the fifteenth day following
the applicable vesting date) through the issuance (including by a “book entry”, or a computerized or manual entry in the
records of the Company or its designated agent) of shares of Common Stock equal to the number of Units that have vested pursuant to this
Award.

 

7.
Dividends. You shall receive no benefit or adjustment to your Award with respect to
any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment.

 

8.
Restrictive Legends. The shares issued under the Award will be endorsed with appropriate
legends as determined by the Company.

 

    	2

     

    

 

9.
Award not a Service Contract.

 

(a)
Your Continuous Service with the Company or an Affiliate is not for any specified term and may be terminated by you or by the Company
or an Affiliate at any time, for any reason, with or without cause and with or without notice. Nothing in this Agreement (including,
but not limited to, the vesting of the Award pursuant to Section 2 or the issuance of the shares subject to the Award), the Plan or any
covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan will: (i) confer upon you any right
to continue in the service of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company
or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition
of service or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically
accrued under the terms of this Agreement or Plan; or (iv) deprive the Company or an Affiliate of the right to terminate you at will
and without regard to any future vesting opportunity that you may have.

 

(b)
By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to Section 2 and the
schedule set forth in the Grant Notice is earned only by continuing as an director, employee or consultant at the will of the Company
or an Affiliate (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has
the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time
to time, as it deems appropriate (a “reorganization”). You further acknowledge and agree that such a reorganization
could result in the termination of your Continuous Service and the loss of benefits available to you under this Agreement, including
but not limited to, the termination of the right to continue vesting in the Award. You further acknowledge and agree that this Agreement,
the Plan, the transactions contemplated hereunder and the vesting schedule set forth in the Grant Notice or any covenant of good faith
and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement as
a director, employee or consultant with the Company or an Affiliate for the term of this Agreement, for any period, or at all, and will
not interfere in any way with your right or the right of the Company or an Affiliate to terminate your Continuous Service at any time,
with or without cause and with or without notice.

 

10.
Responsibility for Taxes.

 

(a)
You acknowledge that, regardless of any action taken by the Company, the ultimate liability for any U.S. federal, state, local and
non-U.S. income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to your
participation in the Plan and legally applicable to you or deemed by the Company in its discretion to be an appropriate charge to you
even if legally applicable to the Company (“Tax-Related Items”) is and remains your responsibility and may
exceed the amount actually withheld by the Company.

 

(b)
Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the
Company to satisfy all Tax-Related Items. In this regard, you authorize the Company or its agent to satisfy their withholding obligations
with regard to all Tax-Related Items, if any, by any of the following means or by a combination of such means: (i) withholding from any
compensation otherwise payable to you by the Company; (ii) requiring you to tender a cash payment prior to the delivery of shares of
Common Stock to you; (iii) entering on your behalf (pursuant to this authorization without further consent) into a “same day sale”
commitment with a broker dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”)
whereby you irrevocably elect to sell a portion of the shares to be delivered under the Award to satisfy the Tax-Related Items and whereby
the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Tax-Related Items directly to the Company and/or
its Affiliates; or (iv) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to you in connection
with the Award with a Fair Market Value (measured as of the date shares of Common Stock are issued pursuant to Section 6) equal to the
amount of such Tax-Related Items. Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering
applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case
you will receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent. If the obligation
for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, you are deemed to have been issued the
full number of shares of Common Stock subject to the vested portion of the Award, notwithstanding that a number of the shares of Common
Stock are held back solely for the purpose of paying the Tax-Related Items.

 

    	3

     

    

 

(c)
Finally, you agree to pay to the Company any amount of Tax-Related Items that the Company may be required to withhold or account
for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse
to issue or deliver the shares or the proceeds of the sale of shares of Common Stock if you fail to comply with your obligations, if
any, in connection with the Tax-Related Items.

 

11.
No Obligation to Minimize Taxes. You acknowledge that the Company is not making representations
or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited
to, the grant, vesting or settlement of the Award, the subsequent sale of shares of Common Stock acquired pursuant to such settlement
and the receipt of any dividends and/or any dividend equivalent payments. Further, you acknowledge that the Company does not have any
duty or obligation to minimize your liability for Tax-Related Items arising from the Award and will not be liable to you for any Tax-Related
Items arising in connection with the Award. Although the Award is intended to comply with the requirements of Section 409A of the Code,
the Company makes no representations to you in that regard.

 

12.
No Advice Regarding Grant. The Company is not providing any tax, legal or financial
advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying
shares of Common Stock. You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the Tax-Related
Items arising in connection with the Award and by accepting the Award, you have agreed that you have done so or knowingly and voluntarily
declined to do so.

 

13.
Unsecured Obligation. The Award is unfunded, and as a holder of a vested Award, you
will be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares pursuant
to this Agreement. You will not have voting or any other rights as a stockholder of the Company with respect to the shares to be issued
pursuant to this Agreement until such shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will
obtain full voting and other rights as a stockholder of the Company. Nothing contained in this Agreement, and no action taken pursuant
to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company
or any other person.

 

14.
Notices. Any notices provided for in the Grant Notice, this Agreement or the Plan will
be given in writing and will be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five
(5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.
Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the
Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent
to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic
system established and maintained by the Company or another third party designated by the Company.

 

    	4

     

    

 

15.
Miscellaneous.

 

(a)
The rights and obligations of the Company under the Award will be transferable to any one or more persons or entities, and all covenants
and agreements hereunder will inure to the benefit of, and be enforceable by, the Company’s successors and assigns. Your rights
and obligations under the Award may only be assigned with the prior written consent of the Company.

 

(b)
You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company
to carry out the purposes or intent of the Award.

 

(c)
You acknowledge and agree that you have reviewed the documents provided to you in relation to the Award in their entirety, have had
an opportunity to obtain the advice of counsel prior to executing and accepting the Award, and fully understand all provisions of such
documents.

 

(d)
This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies
or national securities exchanges as may be required.

 

(e)
All obligations of the Company under the Plan and this Agreement will be binding on any successor to the Company, whether the existence
of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of
the business and/or assets of the Company.

 

16.
Governing Plan Document. The Award is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of the Award, and is further subject to all interpretations, amendments, rules and regulations
which may from time to time be promulgated and adopted pursuant to the Plan. Except as expressly provided herein, in the event of any
conflict between the provisions of the Award and those of the Plan, the provisions of the Plan will control.

 

17.
Severability. If all or any part of this Agreement or the Plan is declared by any court
or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement
or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful
or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the
fullest extent possible while remaining lawful and valid.

 

18.
Effect on Other Benefit Plans. The value of the Award subject to this Agreement will
not be included as compensation, earnings, salaries, or other similar terms used when calculating benefits under any benefit plan sponsored
by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend,
modify, or terminate any of the Company’s or any Affiliate’s benefit plans.

 

19.
Amendment. This Agreement may not be modified, amended or terminated except by an instrument
in writing, signed by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be
amended solely by the Board by a writing which specifically states that it is amending this Agreement, so long as a copy of such amendment
is delivered to you, and provided that, except as otherwise expressly provided in the Plan, no such amendment adversely affecting your
rights in more than a de minimis manner hereunder may be made without your written consent. Without limiting the foregoing, (a)
if one or more of the payments or benefits received or to be received by you pursuant to this Agreement would cause you to incur any
additional tax or interest under Section 409A of the Code, the Company may reform such provision to maintain to the maximum extent practicable
the original intent of the applicable provision without violating the provisions of Section 409A and in the event it is reasonably determined
by the Board that, as a result of Section 409A, payments in respect of this Agreement may not be made at the time contemplated by the
terms hereof without causing you to be subject to taxation under Section 409A, the Company will make such payment on the first day that
would not result in you incurring any tax liability under Section 409A, which, if you are a “specified employee” within the
meaning of Section 409A, shall be the first day following the six-month period beginning on the date of your termination of employment,
and (b) the Board reserves the right to change, by written notice to you, the provisions of this Agreement in any way it may deem necessary
or advisable to carry out the purpose of the grant as a result of any change in applicable laws or regulations or any future law, regulation,
ruling, or judicial decision, provided that any such change will be applicable only to rights relating to that portion of the Award which
is then subject to restrictions as provided herein.

 

    	5

     

    

   

 Attachment
II 

 2018
Equity Incentive Plan

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]